is semaglutide bad for your heart Evaluating the Cardiovascular Benefits of Innovator 2.4 mg (Recombinant DNA (r-DNA)) in Patients With Overweight or Obesity: A Critical Review of Current Evidence A 2025 Lancet analysis of

And we stage it

Many medications are often prescribed off-label for conditions that exceed their original FDA approval

Ozougwu JC, Obimba KC, Belonwu CD, Unakalamba CB

In clinical studies of FDA-approved semaglutide and tirzepatide, meaningful weight loss typically became evident by 8-12 weeks

There is scepticism about the timing of the tennis star's recent transparency - she has just become a spokesperson for Ro, a company which sells GLP-1 brands like Wegovy and Zepbound (known as Mounjaro in the UK) through its weight-loss programme, and her husband is also an investor

Preserved Inhibitory Potency of GLP-1 on Glucagon Secretion in Type 2 Diabetes Mellitus